![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS INFLAMMATION AND INFECTION PART 1
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006 June;50(2):143-6
Copyright © 2006 EDIZIONI MINERVA MEDICA
language: English
Imaging of infection and inflammation with 18F-FDG-labeled leukocytes
Rini J. N., Palestro C. J.
Division of Nuclear Medicine Long Island Jewish Medical Center New Hyde Park, NY, USA
Conventional scintigraphic imaging with 67Ga citrate and in vitro labeled leukocytes is routinely used to evaluate infectious and inflammatory conditions. Recent studies suggest that positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) also may be useful in this setting. Both 67Ga citrate and [18F]FDG are highly sensitive tracers, but their specificity for detecting infection is lower than that of in vitro labeled leukocytes, which is the radionuclide gold standard for imaging most infections. PET has several advantages over conventional scintigraphic techniques, including higher spatial resolution and faster imaging times. In vitro [18F]FDG labeled leukocytes represent an initial attempt to develop an infection-specific, positron-emitting tracer. The experience to date with PET imaging of [18F]FDG labeled leukocytes is reviewed in this article.